New targeted therapy shrinks advanced gastrointestinal tumours for 65% of patients in an early study
A new, targeted cancer therapy for advanced gastrointestinal stromal tumours (GIST) has shown promising early results, with 65 per cent of patients who received velzatinib as first-line treatment experiencing tumour […]
Charities and patients welcome NICE decision to reconsider the removal of a “lifeline” cell therapy from the NHS
Stem cell charity Anthony Nolan, together with Blood Cancer UK and Lymphoma Action, welcome the decision by NICE to reconsider the removal of the CAR T-cell therapy Tecartus (brexucabtagene autoleucel) as a treatment for mantle cell lymphoma. After five years of Tecartus being available on the NHS in England […]
Researchers unmask how changes in a ‘hidden’ network in human lymph nodes affect breast cancer survival
New research funded by Breast Cancer Now has uncovered changes in the structure of lymph nodes that could one day help identify people who are at higher or lower risk […]
Moderna and the University of Oxford receive UK Authorisation to begin Phase 1/2 Study of Investigational mRNA Cancer Vaccine for people with Lynch syndrome
The University of Oxford and Moderna, Inc. (NASDAQ: MRNA) today announced a Phase 1/2 study of mRNA-4194, Moderna’s investigational mRNA-based cancer vaccine for Lynch syndrome, has received Medicines and Healthcare […]
GenesisCare installs new advanced CT scanner & state-of-the-art radiotherapy capability at their specialist outpatient cancer care centre in Milton Keynes
Following their recent announcement of the latest generation CT scanner and radiotherapy equipment being installed at their centre in Bristol, GenesisCare continue their commitment to provide access to high-quality cancer […]
NICE Final Draft Guidance recommends ELAHERE®▼ (mirvetuximab soravtansine), marking the first new treatment recommendation in 20 years for eligible adult patients with platinum-resistant ovarian cancer
AbbVie (NYSE: ABBV) has announced that the National Institute for Health and Care Excellence (NICE) has recommended ELAHERE® (mirvetuximab soravtansine) as a monotherapy treatment option for eligible adults with folate […]
CAR T-cell therapy patient videos launched
Two new animated patient information videos designed to help and support UK patients undergoing CAR T-cell therapy have been launched by Sheffield Teaching Hospitals NHS Foundation Trust. The short easy-to-follow […]
New radiopharmacy suite opens in Humberside
A new Radiopharmacy Suite has opened at Castle Hill Hospital to help patients undergoing tests for serious conditions including cancer. The new suite will support patients from all over Hull, […]
University of Oxford team supported by the Medical Research Council to accelerate AI-designed personalised cancer vaccines
A team at the University of Oxford has received support from the Medical Research Council (MRC) to develop and manufacture a new generation of personalised cancer vaccines using artificial intelligence […]
QEQM team introduce new bowel cancer surgery technique
A grandfather was one of the first in east Kent to have part of his bowel removed and reconnected inside his body. David Haddaway (pictured) had the procedure at the […]
